eMedicine Specialties > Pediatrics: General Medicine > Rheumatology

Weber-Christian Disease

Author: Moise L Levy, MD, Professor, Departments of Pediatrics and Dermatology, Baylor College of Medicine; Chief, Department of Dermatology, Texas Children's Hospital
Contributor Information and Disclosures

Updated: May 8, 2009

Introduction

Background

In 1892, Pfeifer first described the skin condition now known as Weber-Christian disease, or idiopathic lobular panniculitis. In 1925, Weber further depicted the syndrome.1 In 1928, Christian emphasized the significance of fever as part of the syndrome. Henceforth, the syndrome became known as Weber-Christian disease.2,3 The nomenclature of this and other related diseases is confusing, and some authors believe that the eponym should be abandoned and that more specific diagnoses should be made on the basis of pathogenesis or cause.

Diseases such as lupus panniculitis, factitial panniculitis, panniculitis associated with pancreatic disease, histiocytic cytophagic panniculitis, and alpha1-antitrypsin deficiency panniculitis have been differentiated from Weber-Christian disease.4 As Weber-Christian disease is elucidated further, additional diseases will probably be identified as being distinct from Weber-Christian disease.

Pathophysiology

Weber-Christian disease is a skin condition that features recurring inflammation in the fat layer of the skin. The involved areas of skin manifest as recurrent crops of erythematous, sometimes tender, edematous subcutaneous nodules. The lesions are symmetric in distribution, and the thighs and lower legs are affected most frequently. Malaise, fever, and arthralgias frequently occur. Nausea, vomiting, abdominal pain, weight loss, and hepatomegaly may also occur. Because its etiology is unknown, Weber-Christian disease is often referred to as idiopathic lobular panniculitis.5,6

Frequency

United States

Because of the ambiguity of this diagnosis versus other closely related conditions, the frequency of Weber-Christian disease has not been determined.

Mortality/Morbidity

The course of Weber-Christian disease varies and depends on which organs are affected.

  • Weber-Christian disease may involve the lungs, heart, intestines, spleen, kidney, and adrenal glands. In patients with inflammation involving visceral organs, significant morbidity and mortality may occur.
  • In patients with only cutaneous manifestations, the clinical course may be characterized by exacerbations and remissions of the cutaneous lesions for several years before the disorder subsides.

Race

No racial predilection is apparent.

Sex

The disease occurs more often in women, who comprise approximately 75% of reported cases.

Age

Weber-Christian disease may occur in young children but has been reported most frequently in people in the fourth to seventh decades of life.

Clinical

History

Patients with Weber-Christian disease typically have cutaneous and, less frequently, systemic symptoms.

  • Patients affected with Weber-Christian disease describe crops of lesions that appear and resolve during a period of weeks to months. The lesions are often symmetric in distribution, and the thighs and legs are involved most commonly. Individual nodules regress during the course of a few weeks.
  • Systemic symptoms of Weber-Christian disease include malaise, fever, nausea, vomiting, abdominal pain, weight loss, bone pain, myalgia, and arthralgia.
  • The etiology of Weber-Christian disease is unknown, and patients do not report a history of thermal, mechanical, or chemical trauma.

Physical

Physical examination reveals erythematous, edematous, and tender subcutaneous nodules.

  • The nodules are usually symmetric and measure approximately 1-2 cm; however, the nodules may be much larger. The lesions commonly occur on the thighs and lower legs but may also involve the arms, trunk, and face.
  • The individual nodules resolve during a couple of weeks, leaving an atrophic depressed scar.
  • Occasionally, the epidermis overlying the nodules breaks down, and the lesion discharges a brown liquid oil (ie, liquefying panniculitis).
  • In individuals with Weber-Christian disease with visceral involvement, hepatomegaly or splenomegaly may be present.

Causes

Because its etiology is unknown, Weber-Christian disease is called idiopathic lobular panniculitis. Patients with Weber-Christian disease do not report a history of physical trauma.

  • In some patients with Weber-Christian disease, elevated levels of circulating immune complexes have been noted, suggesting an immunologically mediated reaction.
  • Similarities between Weber-Christian disease and alpha1-antitrypsin deficiency suggest that an altered regulation of a normal inflammatory process may be involved.

More on Weber-Christian Disease

Overview: Weber-Christian Disease
Differential Diagnoses & Workup: Weber-Christian Disease
Treatment & Medication: Weber-Christian Disease
Follow-up: Weber-Christian Disease
Multimedia: Weber-Christian Disease
References
Further Reading

References

  1. Weber EP. A case or relapsing nonsuppurative nodular panniculitis. Brit J Derm. 1925;37:301.

  2. Christian HA. Relapsing febrile nodular nonsuppurative panniculitis. Arch Intern Med. 1928;41:338.

  3. Haubrich WS. Weber and Christian of Weber-Christian disease. Gastroenterology. Apr 2008;134(4):912. [Medline].

  4. Valverde R, Rosales B, Ortiz-de Frutos FJ, Rodriguez-Peralto JL, Ortiz-Romero PL. Alpha-1-antitrypsin deficiency panniculitis. Dermatol Clin. Oct 2008;26(4):447-51, vi. [Medline].

  5. Wu F, Zou CC. Childhood Weber-Christian disease: clinical investigation and virus detection. Acta Paediatr. Nov 2007;96(11):1665-9. [Medline].

  6. Sharma AK, Sharma PR. Idiopathic lobular panniculitis (Weber Christian disease): a case report. Kathmandu Univ Med J (KUMJ). Apr-Jun 2006;4(2):243-5. [Medline].

  7. Abuzahra F, Kovacs S, Beermann T, et al. Treatment of relapsing idiopathic nodular panniculitis with clofazimine. Br J Dermatol. Mar 2005;152(3):582-3. [Medline].

  8. Eravelly J, Waters MF. Thalidomide in Weber-Christian disease. Lancet. Jan 29 1977;1(8005):251. [Medline].

  9. Freedberg IM, Eisen AZ, Wolff K. Panniculitis. In: Fitzpatrick's Dermatology in General Medicine. Vol 1. New York, NY: Mc-Graw Hill; 1999:1275-8.

  10. Hood AF, Kwan TH, Mihm ML, Jr. Panniculitis. In: Primer of Dermatopathology. Boston, MA: Little, Brown and Company; 1993:450.

  11. Lazarus GS. Panniculitis and Disorders of the Subcutaneous Fat. [Full Text].

  12. Lebwohl M. Panniculitis. In: Difficult Diagnoses in Dermatology. New York, NY: Churchill Livingstone; 1988:389-91.

  13. Lemley DE, Ferrans VJ, Fox LM, et al. Cardiac manifestations of Weber-Christian disease: report and review of the literature. J Rheumatol. May 1991;18(5):756-60. [Medline].

  14. Moschella SL, Hurley, HJ. Panniculitides. In: Dermatology. Vol 2. Philadelphia, PA: WB Saunders; 1985:1175-6.

  15. Panush RS, Yonker RA, Dlesk A, et al. Weber-Christian disease. Analysis of 15 cases and review of the literature. Medicine (Baltimore). May 1985;64(3):181-91. [Medline].

  16. Schuval SJ, Frances A, Valderrama E, et al. Panniculitis and fever in children. J Pediatr. Mar 1993;122(3):372-8. [Medline].

  17. Usuki K, Kitamura K, Urabe A, Takaku F. Successful treatment of Weber-Christian disease by cyclosporin A. Am J Med. Aug 1988;85(2):276-8. [Medline].

  18. White JW Jr, Winkelmann RK. Weber-Christian panniculitis: a review of 30 cases with this diagnosis. J Am Acad Dermatol. Jul 1998;39(1):56-62. [Medline].

  19. Winkelmann RK, Dahl PR, Perniciaro C, Dahl PM. Asteroid bodies and other cytoplasmic inclusions in necrobiotic xanthogranuloma with paraproteinemia. J Am Acad Dermatol. Jun 1998;38(6 Pt 1):967-70. [Medline].

Keywords

Weber-Christian disease, idiopathic lobular panniculitis, relapsing febrile nodular nonsuppurative panniculitis, nodular nonsuppurative panniculitis, Pfeifer-Weber-Christian syndrome, lupus panniculitis, factitial panniculitis, pancreatic disease, histiocytic cytophagic panniculitis, skin inflammation, skin rash, skin lesions, hepatomegaly, splenomegaly, treatment, diagnosis

Contributor Information and Disclosures

Author

Moise L Levy, MD, Professor, Departments of Pediatrics and Dermatology, Baylor College of Medicine; Chief, Department of Dermatology, Texas Children's Hospital
Moise L Levy, MD is a member of the following medical societies: American Academy of Dermatology, American Academy of Pediatrics, American Society for Laser Medicine and Surgery, Harris County Medical Society, Society for Investigative Dermatology, and Texas Medical Association
Disclosure: Nothing to disclose.

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Thomas JA Lehman, MD, FAAP, FACR, Clinical Professor of Pediatrics, Department of Pediatrics, Division of Pediatric Rheumatology, Weill-Cornell University; Chief, Hospital for Special Surgery
Thomas JA Lehman, MD, FAAP, FACR is a member of the following medical societies: PM American Allergy Society
Disclosure: Nothing to disclose.

CME Editor

Daniel Rauch, MD, FAAP, Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine
Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine
Disclosure: Baxter Honoraria Consulting

Chief Editor

Lawrence K Jung, MD, Chief, Division of Pediatric Rheumatology, Children's National Medical Center
Lawrence K Jung, MD is a member of the following medical societies: American Association for the Advancement of Science, American Association of Immunologists, American College of Rheumatology, Clinical Immunology Society, and New York Academy of Sciences
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.